With Pfizer’s final stake sale in the bag, the two Big Pharma companies behind Haleon’s genesis have formally parted ways with the standalone consumer health giant. | After charting similar moves ...

Pfizer Inc. is poised to raise about £2.55 billion ($3.3 billion) through the sale of its remaining 7.3% stake in Haleon Plc, ...

Pfizer (PFE) stock in focus as the company sells its entire 7.3% stake in Haleon (HLN) for $3.24B. Read more here.

Sensodyne toothpaste maker Haleon hailed an ... company after US pharma giant Pfizer sold its remaining stake in the business. Shares in the consumer health group – originally a joint venture ...

Haleon HLN-2.04%decrease ... and said it expected further organic revenue and profit growth this year. The consumer-health giant, which was spun out of GSK and is partly owned by Pfizer, said ...

Pfizer Inc. (PFE) agreed to sell its remaining stake worth $3.3 billion in Haleon PLC (HLN), marking its exit from the UK-based consumer ...

(Reuters) -Drugmaker Pfizer has sold its entire stake in Haleon for about 2.5 billion pounds ($3.24 billion) to institutional ...

The pharmaceutical giant offered about 618 million ... completing its separation from the consumer health company last year. Haleon posted strong results for the fourth quarter of 2024 at its ...

March 18 (Reuters) - Pfizer (PFE.N), opens new tab will sell its remaining stake in British consumer healthcare group Haleon (HLN.L ... shortfalls in US global health funding March 18, 2025 ...

Pfizer has finalized the sale of its entire holding in Haleon , generating approximately 2.5 billion ($3.24 billion), Reuters ...

0514 ET – Haleon’s earnings-per-share beat signals an turning point, Barclays analysts say in a note. The British consumer-health giant’s historical lack of EPS delivery has been a key ...

Consumer healthcare giant Haleon has reported a strong financial performance for ... Haleon focuses on over-the-counter medicines, oral health, and vitamins, minerals and supplements. Its portfolio ...